Skip to main content
. 2021 May 24;78(7):1–9. doi: 10.1001/jamaneurol.2021.1437

Figure 3. Unadjusted Epilepsy-Free Survival Among 282 Infants With Acute Symptomatic Neonatal Seizures.

Figure 3.

No difference in epilepsy-free survival among infants with acute symptomatic neonatal seizures for whom antiseizure medications (ASMs) were discontinued (orange) vs maintained (blue) at the time of discharge (hazard ratio, 0.8; 95% CI, 0.4-1.5).